CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 743766-743891 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"Visualization of peracute antigen presentation/T cell activation in spleen following high-dose soluble antigen application F.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T64896","span":{"begin":0,"end":125},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T64896","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T241","span":{"begin":0,"end":125},"obj":"Sentence"}],"attributes":[{"subj":"T241","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2326","span":{"begin":68,"end":74},"obj":"Body_part"}],"attributes":[{"id":"A2326","pred":"uberon_id","subj":"T2326","obj":"http://purl.obolibrary.org/obo/UBERON_0002106"},{"subj":"T2326","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#b093ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93ec96"},{"id":"CORD-19-PD-UBERON","color":"#ec93a9"}]}]}}